Category: Top Story
-
Oil Prices Edge Higher as OPEC+ Surprises Markets with Modest Output Increase
Oil prices extended their upward momentum on Tuesday after OPEC+ announced a smaller-than-expected production increase for November, easing concerns over a potential oversupply in the coming months. As of 06:23 GMT, Brent crude futures rose 19 cents, or 0.29%, to $65.66 per barrel, while U.S. West Texas Intermediate (WTI) gained 19 cents, or 0.31%, to…
-
Fifth Third Bancorp to Acquire Comerica in $10.9 Billion All-Stock Merger
Fifth Third Bancorp (NASDAQ:FITB) announced on Monday, October 6, that it will acquire Comerica Inc. (NYSE:CMA) in an all-stock transaction valued at $10.9 billion, a move that will create the ninth-largest bank in the United States. The combined institution will hold approximately $288 billion in assets and a strong presence across the Midwest, Texas, and…
-
BitMine Expands Ethereum Holdings, Strengthening Its Position in Crypto Treasury Strategy
BitMine Immersion Technologies (AMEX:BMN) has significantly boosted its Ethereum (COIN:ETHUSD) holdings, now owning 2.83 million ETH tokens, as part of a broader effort to expand its digital asset treasury. The company’s total cash and crypto reserves have reached $13.4 billion, including $456 million in cash and 192 bitcoins. Last week alone, BitMine acquired 179,251 ETH,…
-
Ed Yardeni Raises S&P 500 Target to 7,000 on Strong U.S. Economy and Improved Sentiment
Yardeni Research has lifted its year-end S&P 500 target back to 7,000, citing the resilience of the U.S. economy and renewed investor optimism following President Trump’s resolution of trade tensions. “We started the year there, but lowered it earlier this year in response to Trump’s Tariff Turmoil,” said Ed Yardeni, President of Yardeni Research. “We…
-
Jefferies Upgrades Ford, Says Automaker Better Positioned Than GM Amid Shifting U.S. Regulations
Ford Motor Co. (NYSE:F) is better equipped than General Motors (NYSE:GM) to navigate the evolving U.S. landscape on emissions and trade policy, according to Jefferies analysts, who upgraded Ford’s stock and highlighted its stronger regulatory flexibility. The brokerage raised its rating on Ford to Hold from Underperform and increased its price target to $12 from…
-
Abivax Shares Surge After Strong Phase 3 Results in Ulcerative Colitis Study
Abivax SA ADR (NASDAQ:ABVX) shares climbed 7.7% in premarket trading Monday after the clinical-stage biotechnology company reported positive Phase 3 results for its experimental ulcerative colitis treatment, obefazimod. The company said its once-daily 50 mg dose of obefazimod produced clinically meaningful improvements across all key endpoints in patients with moderate-to-severe ulcerative colitis, including those who…
-
Dragonfly Energy Shares Sink After Announcing $25 Million Stock Offering
Dragonfly Energy Holdings Corp. (NASDAQ:DFLI) shares tumbled 30% on Monday after the energy storage and battery technology company announced the pricing of a new underwritten public offering. The Nevada-based firm priced 20 million shares of common stock at $1.25 per share, a steep discount from Friday’s closing price of $1.89. The offering is expected to…
-
Heidrick & Struggles Shares Surge After $1.3 Billion Buyout Agreement
Heidrick & Struggles International (NASDAQ:HSII) shares jumped 20% in premarket trading Monday after the global leadership advisory and executive search firm announced it will be acquired by a consortium led by Advent International and Corvex Private Equity in an all-cash transaction valued at approximately $1.3 billion. Under the terms of the agreement, Heidrick shareholders will…
-
HIVE Shares Climb as Bitcoin Output Surges 138% Year Over Year
HIVE Digital Technologies Ltd. (NASDAQ:HIVE) shares rose 6.5% in premarket trading Monday after the company reported a sharp year-over-year increase in Bitcoin production for September. The digital infrastructure firm said it mined 267 Bitcoin last month, an 8% rise from August’s 247 BTC and a 138% increase compared to the 112 BTC mined in September…
-
Gilead Shares Rise After Reaching Settlement on Biktarvy Patent Disputes
Gilead Sciences Inc. (NASDAQ:GILD) shares climbed 4.5% on Monday after the company announced it had resolved patent litigation with several generic drugmakers involving its blockbuster HIV therapy Biktarvy. The biopharmaceutical firm said it has reached settlement agreements with Lupin Ltd., Cipla Ltd., and Laurus Labs Ltd., which had submitted abbreviated new drug applications (ANDAs) to…